首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1622502

全球細胞分離市場規模：按產品、按細胞類型、按細胞來源、按最終用戶、按地區、範圍和預測

Global Cell Isolation Market Size By Product, By Cell Type, By Cell Source, By End User, By Geographic Scope And Forecast

出版日期: 2024年07月30日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

細胞分離市場規模及預測

2023年細胞分離市場規模為98.2億美元，預計到2031年將達到341.3億美元，2024年至2031年複合年增長率為16.85%。細胞分離是指從組織或培養物等複雜組合中移除單一細胞或特定細胞群，同時維持其存活和功能的過程。此方法對於各種生物和醫學研究應用至關重要，包括基於細胞的測定、再生醫學和癌症研究。透過分離細胞，研究人員可以更精確地檢查它們的特性、行為和相互作用，從而深入了解細胞活動、疾病原因和潛在的治療方法。

此外，用於提取不同細胞類型的技術包括機械分離、酶消化、螢光激活細胞分選 (FACS) 和磁激活細胞分選 (MACS)。這些技術基於尺寸、密度、表面標記和其他獨特屬性等因素。

細胞分離市場動態

塑造細胞分離市場的主要市場動態

主要市場驅動因子

生物技術與生命科學的進展：

生物技術和生命科學領域的快速創新，包括自動化和高通量方法，顯著改進了細胞分離程序。這些改進使得特定細胞類型的分離更有效率、準確且經濟高效，進而推動市場成長。

對個人化醫療的需求不斷增加：

對個人化醫療和標靶醫學的日益重視需要分離特定的細胞類型進行研究和開發。因此，細胞分離對於闡明疾病原因、開發診斷方法和設計個人化療法至關重要，也推動了細胞分離技術的市場引入。

慢性病和研究活動的增加：

癌症和糖尿病等慢性病的盛行率不斷上升，增加了對這些疾病的研究需求。因此，細胞分離對於研究疾病的發病機制、發現新的治療技術和藥物至關重要。

增加對細胞療法的投資：

這些療法使用乾細胞和 CAR T 細胞等分離細胞來治療各種疾病。早期細胞藥物的成功和治療疑難雜症的前景吸引了大量投資，並支持細胞分離市場的擴張。

主要問題

技術/操作問題：

細胞分離過程非常精確，技術難度也很大。分離高純度和高活力的細胞，特別是從複雜組織和特定細胞類型中分離，需要先進的技術和程序，限制了市場成長機會。此外，在保持品質和經濟性的同時增加這些步驟的數量也是市場上的一個主要問題。

道德問題：

某些細胞分離應用，特別是那些使用人類胚胎幹細胞或基因操作的應用，引起了細胞分離市場的倫理問題。這種道德問題提高了公眾意識，降低了消費者的接受度，並影響了一些地方的監管法律，從而限制了研究工作和商業利用。

市場競爭與創新壓力：

細胞分離市場競爭激烈，許多競爭對手競相提供創新解決方案。跟上技術的快速進步並降低成本，同時滿足不斷變化的最終用戶需求，需要大量投資，這對維持獲利能力和市場地位構成了重大挑戰。

主要趨勢

自動化與高通量技術：

自動化細胞分離方法以提高通量、消除人為錯誤並提高重現性的趨勢日益明顯。能夠以最少的人力同時處理多個樣本的自動化方法和設備越來越受歡迎，進一步刺激了市場擴張。

幹細胞研究與治療的成長：

幹細胞研究領域的擴展以及幹細胞在治療中的使用不斷增加正在推動對高效細胞分離技術的需求。分離高品質幹細胞已成為再生醫學、組織工程和各種細胞療法的關鍵，推動了維持細胞完整性和活性的溫和高效分離技術的進步。

特定細胞分離的先進技術：

FACS 和 MACS 技術的進步提高了分離細胞的純度和活力。基於微流體的細胞分離技術的發展也在不斷發展，即使在異質樣本中也能夠精確識別特定細胞類型，這對於研究、治療和診斷至關重要。

細胞分離市場的區域分析

細胞分離市場的詳細區域分析

北美：

根據經過驗證的市場研究，預計北美將在預測期內主導細胞分離市場。該地區在醫療保健和生物技術行業，特別是基於細胞的研究和製藥領域進行了大量的財務投資。這些投資使得尖端細胞分離技術和服務的創造和商業化成為可能，從而推動市場成長。

北美是個人化醫療領域的先驅，主要依靠以細胞為基礎的治療和診斷。對幹細胞治療和免疫治療等個人化治療的需求，需要精確的細胞分離和分析，正在推動細胞分離技術市場的發展。

此外，北美的監管環境，特別是透過 FDA（美國食品藥物管理局），促進了生物技術和製藥領域的創新。細胞藥物和產品的監管流程十分完善，能夠快速批准並接受創新技術。這種有利的監管框架鼓勵公司開發和傳播新的細胞分離技術和產品。

歐洲

歐洲擁有完善的醫療保健體系，在醫療保健上花費大量資金，因此很容易獲得細胞分離等最新的醫療技術。這種基礎設施使持續的醫學研究和創新療法的開發成為可能，從而實現穩定的市場成長。

歐洲的人口老化和慢性疾病負擔的增加需要尖端的診斷和治療技術，包括基於細胞的藥物。研究和臨床應用中對精確細胞分離的需求正在推動市場擴張。

此外，歐盟 (EU) 為生物醫學研究提供全面的監管框架和融資體系，並促進細胞分離技術的創新。例如，地平線歐洲鼓勵研究合作，同時推動技術和擴大市場。

亞太地區：

預計亞太地區在預測期內將以最高的複合年增長率成長。由於政府當局增加的投資和支持，亞太地區的生技公司正在蓬勃發展。這種擴張創造了對研發、生物製藥生產和臨床診斷所必需的細胞分離技術的需求。

隨著政府和私營部門對醫院和研究機構的投資，該地區的醫療保健基礎設施正在迅速擴張。這種擴張促進了尖端技術的使用，例如用於製藥和診斷目的的細胞分離。

此外，亞太地區面臨著癌症和糖尿病等慢性疾病日益沉重的負擔，需要新的診斷和治療方法。因此，細胞分離對於個人化醫療和客製化治療的進一步應用至關重要，從而推動市場成長。

Cell Isolation Market size was valued at USD 9.82 Billion in 2023 and is projected to reach USD 34.13 Billion by 2031 , growing at a CAGR of 16.85% from 2024 to 2031. Cell isolation refers to the process of removing individual cells or specific cell populations from a complicated combination, such as tissues or cultures, while keeping them viable and functional. This method is essential for a variety of biological and medical research applications, including cell-based assays, regenerative medicine, and cancer research. By isolating cells, researchers can examine their properties, behavior, and interactions with greater precision, yielding insights into cellular activities, disease causes, and potential therapeutic approaches.

Additionally, the techniques used to extract different cell types are mechanical separation, enzymatic digestion, fluorescence-activated cell sorting (FACS), magnetic-activated cell sorting (MACS), and others. These techniques are based on factors like size, density, surface markers, or other unique characteristics.

Cell Isolation Market Dynamics

The key market dynamics that are shaping the Cell Isolation Market include:

Key Market Drivers

Advancements in Biotechnology and Life Sciences:

Rapid technical breakthroughs in biotechnology and life sciences, such as automation and high-throughput approaches, have greatly enhanced cell isolation procedures. These improvements enable more efficient, precise, and cost-effective isolation of certain cell types, resulting in market growth.

Growing Demand for Personalized Medicine:

The growing emphasis on personalized medicine and targeted medicines demands the separation of certain cell types for research and development. As a result, cell isolation becomes essential for understanding disease causes, generating diagnostics, designing personalized therapeutics, and also bolstering market adoption of cell isolation techniques.

Increase in Chronic Diseases and Research Activities:

The increasing prevalence of chronic diseases like cancer and diabetes is increasing the demand for research into these conditions. Thus, cell isolation serves essential for studying disease pathogenesis, leading to new therapy techniques and medication discoveries.

Growing Investments in Cell-based Therapies:

These therapies cure a variety of disorders by using isolated cells such as stem cells or CAR T cells. The success of early cell-based medicines, as well as their promise to treat difficult illnesses, have attracted significant investment, supporting the expansion of the Cell Isolation Market.

Key Challenges:

Technical and Operational Challenges:

Cell isolation procedures are very precise and technically difficult. Isolating cells with high purity and viability, especially from complex tissues or for specific cell types, necessitates advanced technology and procedures, limiting market growth opportunities. Also, increasing these processes while preserving quality and economy presents considerable problems in the market.

Ethical Concerns:

Certain cell isolation applications, particularly those that use human embryonic stem cells or genetic manipulation, create concerns regarding ethics in the Cell Isolation Market. These ethical considerations raise public awareness and lower consumer acceptance and influence regulatory laws, thereby limiting research activity and commercial uses in some places.

Market Competition and Innovation Pressure:

The Cell Isolation Market is competitive, with many competitors competing to provide innovative solutions. Keeping up with rapid technological improvements and addressing the changing needs of end users while controlling costs demands significant investment and presents a substantial challenge for preserving profitability and market position.

Key Trends:

Automation and High-throughput Technologies:

There is an increasing trend of automating cell isolation methods in order to boost throughput, eliminate manual errors, and improve reproducibility. Automated methods and equipment capable of processing several samples at the same time with minimal human interaction are gaining popularity and further stimulating market expansion.

Growth in Stem Cell Research and Therapy:

The expanding field of stem cell research, as well as the increased use of stem cells in therapeutic therapies, are driving demand for efficient cell isolation techniques. Isolating high-quality stem cells has become essential for regenerative medicine, tissue engineering, and diverse cell therapies, which is driving advancements in gentle and efficient isolation technologies that preserve cell integrity and activity.

Advanced Techniques for Specific Cell Isolation:

FACS and MACS techniques are advancing, resulting in improved purity and viability of separated cells. The development of microfluidics-based cell isolation technologies is also on the rise, enabling the exact identification of certain cell types, even from heterogeneous samples, which is vital to research, therapy, and diagnostics.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Cell Isolation Market Regional Analysis

Here is a more detailed regional analysis of the Cell Isolation Market:

North America:

According to Verified Market Research, North America is estimated to dominate the Cell Isolation Market over the forecast period. The region has experienced significant financial investment in the healthcare and biotechnology industries, especially cell-based research and medicines. These investments enable the creation and commercialization of cutting-edge cell separation technologies and services, resulting in market growth.

North America is a pioneer in the field of personalized medicine, which is mainly reliant on cell-based therapies and diagnoses. The demand for personalized treatments, such as stem cell therapies and immunotherapies, necessitates precise cell isolation and analysis, driving the market for cell isolation technologies.

Furthermore, North America's regulatory environment, particularly in the United States through the FDA (FDA), fosters innovation in the biotechnology and pharmaceutical sectors. The regulatory processes for cell-based medicines and goods are well established, allowing for faster approval and acceptance of innovative technology. This favorable regulatory framework encourages companies to develop and promote new cell isolation technologies and products.

Europe:

Europe has well-established healthcare systems and significant healthcare spending, thereby offering easy accessibility to modern medical technology, such as cell isolation. This infrastructure enables continued medical research and the deployment of innovative therapeutics, resulting in consistent growth in the market.

Europe's ageing population and rising chronic illness burden demand cutting-edge diagnostic and therapeutic techniques, including cell-based medicines. The requirement for precise cell separation in research and clinical applications is fueling market expansion.

Furthermore, the European Union provides comprehensive regulatory frameworks and financing systems for biomedical research, promoting innovation in cell isolation technology. Horizon Europe, for instance, encourages research cooperation while also advancing technology and expanding the market.

Asia Pacific:

Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Asia-Pacific's biotechnology companies are booming, owing to increased investment and support offered by the government authorities. This expansion is generating demand for cell separation technologies, which are critical for research and development, biopharmaceutical production, and clinical diagnostics.

The region's healthcare infrastructure is rapidly expanding, with both governments and the private sector investing in hospitals and research organizations. This expansion promotes the use of modern technologies such as cell isolation for medicinal and diagnostic purposes.

Furthermore, Asia Pacific faces an increasing burden of chronic diseases such as cancer and diabetes, necessitating new diagnostic and therapeutic approaches. As a result, cell isolation is becoming essential for further application in personalized medicine and tailored therapeutics, driving market growth.

Cell Isolation Market: Segmentation Analysis

The Cell Isolation Market is Segmented based on Product, Cell Type, Cell Source, End User, and Geography.

Cell Isolation Market, By Product

Consumables
Reagents, Kits, Media & Sera
Beads
Disposables
Instruments
Centrifuges
Cell Sorters
Magnetic-activated Cell Separator Systems
Filtration Systems

Based on Product, the market is segmented into Consumables and Instruments. The consumables segment is estimated to dominate the Cell Isolation Market. Consumables such as reagents, kits, medium, sera, beads, and disposables have vital and recurring requirements in cell isolation techniques, necessitating repeated purchases. These materials are essential for both basic research and clinical applications, resulting in significant demand from a diverse spectrum of end users, including research laboratories, biotechnology and pharmaceutical businesses, and healthcare providers. Furthermore, the introduction of specialized consumables that improve the efficiency and specificity of cell isolation techniques has accelerated their adoption.

Cell Isolation Market, By Cell Type

Human Cells
Animal Cells

Based on Cell Type, the market is segmented into Human Cells and Animal Cells. The human cells segment is estimated to dominate the Cell Isolation Market during the forecast period due to the widespread use of human cells in a variety of applications, such as biomedical research, regenerative medicine, cancer research, and cell-based therapeutics. The increased emphasis on personalized medicine, which frequently uses human cell models to investigate disease causes and evaluate therapeutic therapies, fuels the demand for human cell isolation. Furthermore, increased investment in stem cell research and the rising prevalence of chronic diseases is surging the application of cell-based treatments, leading to greater demand for human cells than animal cells.

Cell Isolation Market, By Cell Source

Bone Marrow
Adipose Tissues
Cord Blood/Embryonic Stem Cells
Other Cell Sources

Based on Cell Source, the market is segmented into Bone Marrow, Adipose Tissues, Cord Blood/ Embryonic Stem Cells, and Other Cell Sources. The bone marrow segment is estimated to exhibit the highest growth within the Cell Isolation Market due to the crucial function of bone marrow-derived cells in a variety of therapeutic applications, such as regenerative medicine, hematopoietic stem cell transplantation, and immune system reconstitution. Bone marrow cells are the primary source of mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs), which are required to cure a variety of hematological illnesses, restore bone and cartilage, and conduct research and development on new medicines.

Cell Isolation Market, By End User

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Laboratories
Other End Users

Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories, and Other End Users. The pharmaceutical & biotechnology companies segment is estimated to dominate the Cell Isolation Market due to these businesses' significant spending in research and development (R&D) efforts, particularly in the creation of innovative medicines, vaccines, and diagnostics that necessitate high-purity cell isolates for efficacy and safety tests. Furthermore, the push for personalized medicine and sophisticated medicines, such as cell and gene therapies, has increased the demand for accurate cell isolation technology.

Key Players

The "Global Cell Isolation Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
Thermo Fisher Scientific, Miltenyi Biotec, BD Biosciences, Merck, Eppendorf, GE Healthcare, Danaher Corporation, PerkinElmer, Agilent Technologies, Bio-Rad Laboratories, Takara Bio, Sigma-Aldrich, Promega Corporation, Lonza, Cell Signaling Technology, STEMCELL Technologies, Miltenyi Biotec, Apogee Flow Systems, and Fluidigm Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

In February 2024, Miltenyi Biotec introduced a new microfluidic platform for high-throughput cell isolation. This approach offers faster and more efficient separation of rare cell populations, which could aid fields such as cancer research and personalized treatment.
In February 2024, BD Biosciences and Roche collaborated to develop a new cancer cell therapy. This cooperation combines BD's cell isolation capabilities with Roche's immunotherapies to develop more effective cancer treatments.
In February 2024, Eppendorf acquired a cell manipulation company, expanding its cell isolation portfolio. This acquisition increases Eppendorf's position in the cell separation sector, providing researchers with a broader choice of tools and technology.
In February 2024, Agilent Technologies partnered with academic institutions to develop novel cell isolation techniques. This collaboration intends to boost cell isolation research, which could lead to breakthroughs.

1 INTRODUCTION OF GLOBAL CELL ISOLATION MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CELL ISOLATION MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL CELL ISOLATION MARKET, BY PRODUCT

5.1 Overview
5.2 Consumables
- 5.2.1 Reagents, Kits, Media & Sera
- 5.2.2 Beads
- 5.2.3 Disposables
5.3 Instruments
- 5.3.1 Centrifuges
- 5.3.2 Cell Sorters
- 5.3.3 Magnetic-activated Cell Separator Systems
- 5.3.4 Filtration Systems

6 GLOBAL CELL ISOLATION MARKET, BY CELL-TYPE

6.1 Overview
6.2 Human Cells
6.3 Animal Cells

7 GLOBAL CELL ISOLATION MARKET, BY CELL SOURCE

7.1 Overview
7.2 Bone Marrow
7.3 Adipose Tissues
7.4 Cord Blood/Embryonic Stem Cells
7.5 Other Cell Sources

8 GLOBAL CELL ISOLATION MARKET, BY END USER

8.1 Overview
8.2 Pharmaceutical & Biotechnology Companies
8.3 Academic & Research Institutes
8.4 Hospitals & Diagnostic Laboratories
8.5 Other End Users

9 GLOBAL CELL ISOLATION MARKET, BY GEOGRAPHY

9.1 Overview
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 U.K.
- 9.3.3 France
- 9.3.4 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Rest of Asia Pacific
9.5 Rest of the World
- 9.5.1 Latin America
- 9.5.2 Middle East & Africa

10 GLOBAL CELL ISOLATION MARKET COMPETITIVE LANDSCAPE

10.1 Overview
10.2 Company Market Ranking
10.3 Key Development Strategies

11 COMPANY PROFILES

11.1 Thermo Fisher Scientific
- 11.1.1 Overview
- 11.1.2 Financial Performance
- 11.1.3 Product Outlook
- 11.1.4 Key Developments
11.2 Miltenyi Biotec
- 11.2.1 Overview
- 11.2.2 Financial Performance
- 11.2.3 Product Outlook
- 11.2.4 Key Developments
11.3 BD Biosciences
- 11.3.1 Overview
- 11.3.2 Financial Performance
- 11.3.3 Product Outlook
- 11.3.4 Key Developments
11.4 Merck
- 11.4.1 Overview
- 11.4.2 Financial Performance
- 11.4.3 Product Outlook
- 11.4.4 Key Developments
11.5 Eppendorf
- 11.5.1 Overview
- 11.5.2 Financial Performance
- 11.5.3 Product Outlook
- 11.5.4 Key Developments
11.6 GE Healthcare
- 11.6.1 Overview
- 11.6.2 Financial Performance
- 11.6.3 Product Outlook
- 11.6.4 Key Developments
11.7 Danaher Corporation
- 11.7.1 Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Outlook
- 11.7.4 Key Developments
11.8 PerkinElmer
- 11.7.1 Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Outlook
- 11.7.4 Key Developments
11.9 Agilent Technologies
- 11.7.1 Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Outlook
- 11.7.4 Key Developments
11.10 Bio-Rad Laboratories
- 11.7.1 Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Outlook
- 11.7.4 Key Developments